FDA Investigator Lisa C Lewis
Lisa C Lewis has conducted inspections on 15 sites in 1 countries as of 29 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Lisa C Lewis:
Aditi S Thakur,
Alicia M Mozzachio,
Amanda S Zorn,
Ana L Kewes,
Anthony R Ronga,
Arsen Karapetyan,
Brian D Nicholson,
Brian P Emanuel,
Bruce H Mccullough,
Bryan L Mcguckin,
Carlyn L Ray,
Carrie Ann Plucinski,
Charles H Spivey,
Charlie P Booker,
Chase S Baldwin,
Cheryl A Kmiec,
Christina A Miller,
Christopher B Harding,
Christopher D Leach,
Clotia Cabbey Mensah,
Daniel J Brown,
David Perkins,
Debra I Love,
Eric S Pittman,
Gregory R Dill,
Humera T Khan,
James W Plucinski,
Jason F Chancey,
Jennifer C Johnson,
Jesse A Vazquez,
Jocelyn C Turner,
Joshua M Adams,
Justin A Boyd,
Kujtim Sadiku,
Lana K Waselewski,
Lawrence J Stringer,
LCDR Mark A Jimenez, RN,
Lequita M Mayhew,
Leslie D Hintz,
Liliya V Bubiy,
Linda F Murphy,
Mark I Kaspar,
Matthew J Sienko,
Michele L Glendenning,
Nibin Varghese, MS,
Nicholas F Lyons,
Nicole J Clausen,
Norman L Brown,
Pablo Alcantara,
Patricia A Mcilroy,
Patrick E Gainer,
Phung Thien Nguyen,
Robert D Tollefsen,
Rosemary Wood Sexton,
Russell K Riley,
Ruth Smith,
Ryan S Martin,
Sandra A Boyd,
Sarah E Rhoades,
Stephanie A Wright,
Sullan,
Susan P Bruederle,
Susan W Ciani,
Thomas W Nojek,
Thunder N Dunkijacobs,
Todd M Stankewicz,
William G Nelson,
William R Weissinger,
Yvonne E Lozano
Lisa C Lewis's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2003 | EIR | Morton Grove Pharmaceuticals, Inc. - EIR, 2003-02-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more